Trials / Completed
CompletedNCT03580252
Reliability of Hammersmith Examination in Prediction of Neurological Outcomes (REHAPENO)
Reliability of Hammersmith Examination in Prediction of Neurological Outcomes In Preterm Infants - Observational Study (REHAPENO)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- Abha International Private Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
In this study workers are trying to test the correlation between Hammersmith Infant Neurological Examination and MRI brain/cranial ultrasound with early prediction of neurological developmental outcome of preterm neonates. This study is prospective cross-sectional collecting the data of patients according to daily standard medical practice
Detailed description
The primary aim of this study is to evaluate the neurobehavioural performance of infants born preterm using the Hammersmith Infant Neurological Examination (HINE) in standard medical practice and compare it with the gold standard MRI and ultrasound imagings. It would be possible to check do we need to use all the 3 examinations or Hammersmith examination would be enough reliable predictor. Secondary aim is to explore the relationships between MRI brain /cranial us abnormalities and HINE at term-equivalent age in infants born preterm in prediction of neurological outcome at 1 year of chronological age. This study will be only single arm/single group. This group would receive the regular practice of MRI, Ultrasound (US) and Hammersmith assessments. The 3 assessments would be compared in relationships with the neonatal developmental outcomes (developmental milestones).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Correlation analyses for the outcomes | No medical intervention would be done. The single arm would receive regular practice of Hammersmith Assessment and MRI / Ultrasound |
Timeline
- Start date
- 2018-03-01
- Primary completion
- 2019-01-25
- Completion
- 2019-01-25
- First posted
- 2018-07-09
- Last updated
- 2019-01-28
Locations
1 site across 1 country: Saudi Arabia
Source: ClinicalTrials.gov record NCT03580252. Inclusion in this directory is not an endorsement.